Modafinil vs Vitamin D for energy
Short answer: For energy, users rate them about the same: 91% report improvement with Modafinil (307 reports) and 87% with Vitamin D (215 reports).
Modafinil has 155 meta-analyses and 297 randomized trials on PubMed; Vitamin D has 3,251 and 4,560.
Based on 1,116 reports about Modafinil and 2,323 about Vitamin D. Not medical advice.
| Modafinil Medication | Vitamin D Supplement | |
|---|---|---|
| User score | 45 | 48 |
| Verdict | Mixed | Mostly positive |
| Positive of reports that state an outcome | 48% | 65% |
| Reports | 1,116 | 2,323 |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 155 / 297 | 3,251 / 4,560 |
| Mainly used for | ||
| Weight loss % reporting improvement | 100% (5) | 62% (8) |
| Appetite % reporting improvement | 40% (15) | 67% (3) |
| Focus % reporting improvement | 84% (454) | 82% (55) |
| Energy % reporting improvement | 91% (307) | 87% (215) |
| Sleep % reporting improvement | 19% (75) | 50% (105) |
| Anxiety % reporting improvement | 26% (73) | 65% (82) |
| Mood % reporting improvement | 62% (90) | 88% (308) |
| Memory % reporting improvement | 71% (21) | 83% (12) |
| Performance % reporting improvement | 88% (17) | 100% (23) |
| Recovery % reporting improvement | — | 91% (11) |
| Pain & inflammation % reporting improvement | — | 73% (30) |
| Digestion % reporting improvement | — | 50% (14) |
| Libido % reporting improvement | 33% (9) | 80% (45) |
| Hormones % reporting improvement | — | 87% (55) |
| Blood sugar % reporting improvement | — | 100% (2) |
| Heart & lipids % reporting improvement | 9% (11) | 60% (15) |
| Skin & hair % reporting improvement | 50% (2) | 89% (28) |
| Immunity % reporting improvement | — | 99% (74) |
| Longevity % reporting improvement | — | 78% (9) |
| Common side effects | insomnia, anxiety, headache, tolerance | insomnia, anxiety, fatigue, hypercalcemia |
| Typical dose reported | as needed | daily |
Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADHD. New research should be funded urgently to assess long-term effects of these drugs.
Lancet Psychiatry, 2018 ↗“It did make me focused and alert. I was working two jobs at the time and needed every ounce of energy I could muster.”
These results indicate that the prevalence of vitamin D deficiency was more elevated in obese subjects. The vitamin D deficiency was associated with obesity irrespective of age, latitude, cut-offs to define vitamin D deficiency and the Human Development Index of the study location.
Obes Rev, 2015 ↗“First thing I noticed was my mood & libido, I have more 'feeling/sensitivity' down there.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate